Search

D-EYE device versus direct ophthalmoscope

D-EYE digital ophthalmoscope is a fundus camera device that attaches to a smartphone and is used in conjunction with a HIPAA-compliant app. The authors conducted a study in which 25 medical students examined the fundi of two undilated patients with...

Fenofibrate and diabetic retinopathy

Fenofibrate is an agonist of peroxisome proliferator-activated receptor-alpha (PPARα) which is used as a lipid-lowering agent. By reducing blood lipid levels, it can decrease retinal hard exudates which is beneficial in diabetic retinopathy (DR). FIELD and ACCORD studies show that...

Protecting retinal ganglion cells

Glaucoma is considered to be a heterogeneous group of conditions giving retinal ganglion cells (RGC) damage. Lowering intraocular pressure (IOP) reduces the risk of progressive RGC loss in glaucoma. Regeneration of the optic nerve has been shown to restore some...

Unveiling Diabetes – Historical Milestones Diabetology (Frontiers in Diabetes)

For readers who may not be familiar with the history of diabetes research, this book provides an insight into the personalities that made major contributions; the recognition and honours conferred on those individuals and their respective colleagues, and the forgotten,...

DSEK – five year results

This UK based study examined long-term descemet stripping endothelial keratoplasty (DSEK) results, looking at graft survival and endothelial cell losses. Data on 210 grafts were included in analysis. Most frequent indication for DSEK was Fuch’s endothelial dystrophy (81.4%) and 46.3%...

Systemic pharmacology of intravitreal anti-VEGF

This study aimed to evaluate and compare serum drug concentrations and plasma free-VEGF concentrations in patients with AMD, DME, or RVO receiving intravitreal injections of aflibercept, bevacizumab or ranibizumab. This prospective study enrolled patients from several offices of a single...